HPV Vaccine Uptake in Cancer Centers

Overview

In response to the President’s Cancer Panel’s report Accelerating HPV Vaccination Uptake: Urgency for Action to Prevent Cancer, three rounds of supplements were issued to NCI-designated cancer centers that focused on increasing HPV vaccination rates in regions with low HPV vaccination uptake. NCI funded 18 supplements in 2014, 12 supplements in 2017, and 11 supplements in 2020.

The HPV Cancer Center Consortium emerged as part of a broader initiative that brought together cancer centers, researchers, and healthcare practitioners with the shared goal of increasing HPV vaccine utilization and reducing HPV-related cancers.

This consortium is dedicated to cancer control, conducting research, strategic planning, fostering professional collaborations, and implementing initiatives to enhance healthcare.

Resources

• Administrative Supplements for NCI-Designated Cancer Centers to Support Collaborations to Enhance HPV Vaccination in Pediatric Settings: A Summary Report (June 2016) (PDF, 1.1 MB)
• Administrative Supplements for NCI-Designated Cancer Centers to Investigate HPV Vaccine Uptake (PDF, 459 KB)
• Accelerating HPV Vaccination Uptake: Urgency for Action to Prevent Cancer (President's Cancer Panel Report, February 2014) (PDF)
• Cancer Moonshot℠ Blue Ribbon Panel Report
• HPV Vaccination for Cancer Prevention: Progress, Opportunities, and a Renewed Call to Action (November 2018)
• HPV Cancer Center Supplement Final Report (June 2016) (PDF, 1.1 MB)
• NCI-designated Cancer Center Joint Statement in Support of HPV Vaccination (PDF, 3.0 MB)
• Research to Reality: HPV Vaccine Uptake Learning Community
• Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional), PAR-19-360

Annual Meeting

2024 Annual Meeting

On April 16 & 17, 2024, the University of Kentucky Markey Cancer Center in Lexington, Kentucky will host the National Cancer Institute (NCI) HPV Cancer Center Consortium in an in-person meeting to discuss healthcare system interventions, emerging research areas, understanding disparities in HPV vaccinations, and more.

2023 Annual Meeting

On February 17 & 22, 2023, the NCI reconvened the HPV Cancer Center Consortium to discuss the future of HPV-related cancers and sustaining cancer center partnerships.

Consortium Webinars

HPV Age 9 Webinar

September 28, 2023 from 2 p.m. – 3 p.m. E.T.
This webinar focuses on the emerging evidence on HPV vaccination at age 9.

Catch-up HPV Vaccination: Addressing intersectionality to achieve equity

November 2, 2023 from 2 p.m. – 3 p.m. E.T.
This webinar focuses on addressing intersectionality to achieve equity and will include topics on catch-up HPV vaccination among young adults during the COVID- 19 pandemic and with vulnerable groups such as minoritized individuals and childhood cancer survivors.

Contacts

For additional information on division-wide efforts in NCI-designated cancer centers, please visit the NCI's Division of Cancer Control and Population Sciences website.